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Diabetes mellitus is one of the world's major chronic health problems. In the United States alone, this metabolic disorder affects an estimated 15.7 million individuals, 5.9% of the (1) population. Among men and women over 65 years of age, where the rates of edentulism are highest, an estimated 18.4% of the individuals have some form of disease.
A complex syndrome with more than one cause, diabetes is responsible for numerous complications affecting the whole body. In the oral environment, it has been associated with xerostomia, increased levels of salivary glucose, swelling of the parotid gland, and an increased (2) incidence of caries. Adult diabetics also experience a 2.8 to 3.4 times higher risk of developing (3) periodontitis than nondiabetics. Although there has been some conflicting evidence, diabetic patients (4) (5) (6) seem to be more prone to infection. Healing after surgery in the diabetic patient seems to occur more slowly, exposing the tissues to complications (7) such as tissue necrosis. Furthermore, animal studies indicate that streptozotocin-induced diabetes interferes with the process of (8, 9) osseointegration.
Because of such considerations, diabetes has sometimes been considered a contraindication for the use of dental implants. The 1988 National Institute of Health Consensus Development Conference (10) Statement on Dental Implants stopped short of explicitly stating this, but did include "debilitating or uncontrolled disease" and "conditions, diseases, or treatment that severely compromise healing" within its list of contraindications for dental implants.
Tempering concerns about the increased risk of implant failure in the diabetic patient, however, has been the growing awareness of the benefits provided by modern dental implants. First developed in the 1960s and commercially introduced 20 years later, implants represent a significantly better solution for tooth loss replacement than traditional dental appliances. Because they are anchored directly into bone, they provide complete stability, in contrast to traditional tooth-replacement alternatives such as dentures. They also minimize bone resorption and atrophy, conditions that can cause facial collapse and the resultant appearance of premature aging. Five-year survival rates of more than 95% in studies of implants supporting mandibular (11, 12) overdentures have become common, and research has demonstrated improved masticatory function and overall satisfaction in implant (13, 14) patients.
Since 1982, the worldwide market for dental implants has grown to approximate $450 million. A 1998 trend survey in the trade journal Dental Products Report reported that >50% of oral surgeons and periodontists reported placing more implants in 1997 than in the prior year.
At the same time, as techniques for managing diabetes have evolved, evidence has accumulated that diabetic patients who effectively control their disease incur a lower risk of various health complications than uncontrolled patients. For example, it has been demonstrated that well-controlled diabetics respond well to periodontal therapy and have fewer systemic complications than poorly controlled (15) diabetics. Before exogenous insulin was widely available, the caries incidence in diabetics was high; but since insulin therapy has become commonplace, most studies have failed to demonstrate an increased caries (2) incidence in treated patients. Similarly, rates of infection seem to be worse in uncontrolled (5) diabetics.
Awareness of such distinctions has resulted in a greater degree of openness to the idea that diabetic patients may be good candidates for dental implants. A few studies have directly addressed this question in recent years and yielded promising preliminary data. In 1998, Kapur et (16) al compared 37 diabetic patients who received conventional removable mandibular overdentures versus 52 who were fitted with implant supported ones and concluded that implants can be successfully used in diabetic patients with even low to moderate levels of metabolic control. A 1994 study found a 92.7% implant success rate for Type II diabetic patients under (17) acceptable glucose control. This article reports on results obtained by the authors after placing 227 implants in 34 diabetics patients.
Methods and Materials
The study population (Table 1) included 17 males and 17 females ranging in age from 34 to 79 years. The average age was 62.1 years (SD, 11.4). Two of the subjects, both male, were smokers. Diabetic status was generally determined from patient health histories or personal interviews. All patients were questioned about how their disease was being treated, and all were urged to strive for optimal metabolic control at the time of implant placement. In addition, a 10-day course of wide-spectrum antibiotics was begun for all subjects on the day of surgery.
Between April 1987 and May 1998, the study subjects were treated with a total of 227 implants, an average of 6.7 implants per person. Table 2 shows the anatomical distribution. Virtually all of the fixtures placed were Branemark System implants. Implant lengths ranged from 7.0 to 20.0mm Approximately 190 were between 10 and 18 mm long. Table 3 details the distribution of implants by length.
Of the 227 total implants, 91 were placed in fresh extraction sites. The remaining 136 implants were placed in osteotomies created by standard drilling techniques. Four of the 227 implants were loaded immediately after placement, all in the same patient. This individual was fitted simultaneously with 11 other implants that were not immediately loaded. Bone grafting was utilized at 31 of the 227 sites.
Thirty of the original 34 patients were followed through uncovering and the final restoration of 177 implants. The healing period between the first-and second-stage surgeries ranged from 0 to 15.5 months, with 5.9 months being the average healing period per implant.
Results
Upon uncovering, 214 of the 227 implants were found to have osseointegrated, a success rate of 94.3%. Of the thirteen failed implants, four occurred in each of two patients (both nonsmokers), two occurred in one patient (also a nonsmoker), and one occurred in each of three patients. Of the latter, one was a smoker.
Of the four implants that were loaded (18) immediately, three failed. In the same patient, a second implant that was not immediately loaded also failed.
Six of the 13 surgical failures were located in the posterior mandible, four were in the posterior maxilla, two were in the anterior maxilla, and one was in the anterior mandible. Table 4 summarizes the location, diameter, length, and healing period of all the failed implants.
Of the 31 grafted sites, one (3.2%) failed. Autogenous bone, Grafton Gel (Musculoskeletal Transplant Foundation, Holmdel, NJ), and a membrane also were used at this site.
Of the 177 implants that were followed through final restoration, one failure was identified; a failure rate of only 0.06%. This implant, which was initially placed in a grafted site in the left maxilla and restored 5 months later, had a 3.75-mm diameter and a length of 10mm. The cause of the failure seemed to be occlusal overload caused by bruxism. 5--The deleterious impact of smoking on osseointegrated implants has been well (19) documented. Although the results of this study suggest that diabetics who smoke can experience success with dental implants, the authors believe that 2--If the diabetic patient's metabolic control seems to be clinically inadequate, it is best to delay implant therapy until better control is achieved. 3--The doctor should stress to the patient the importance of taking all diabetic medications on the days of surgery and maintaining an acceptable level of metabolic control throughout the healing period 4--A 10-day regimen of broad spectrum antibiotics should be started on the day of surgery to reduce the risk of infection . the combination of smoking and diabetes may substantially increase the risks of implant failure. For that reason, diabetic patients who smoke should be urged to enter a smoking cessation program before implant surgery.
Conclusion
Dental implants offer significant benefits that require that they be considered for the treatment of a wide spectrum of patients, including the growing number of individuals with diabetes mellitus. Although uncontrolled diabetes has been shown to interfere with various aspects of the healing process, the results of this retrospective study indicate that a high success rate is achievable when dental implants are placed in diabetic patients whose disease is under control.
